Brooks Laboratories Ltd (BROO.BO)
BROO.BO on Bombay Stock Exchange
16.60INR
23 May 2013
16.60INR
23 May 2013
Price Change (% chg)
Rs-0.55 (-3.21%)
Rs-0.55 (-3.21%)
Prev Close
Rs17.35
Rs17.35
Open
Rs18.80
Rs18.80
Day's High
Rs18.80
Rs18.80
Day's Low
Rs16.25
Rs16.25
Volume
4,102
4,102
Avg. Vol
7,985
7,985
52-wk High
Rs25.35
Rs25.35
52-wk Low
Rs14.40
Rs14.40
BROO.BO
About
Brooks Laboratories Limited (Brooks Laboratories) is a pharmaceutical contract research and manufacturing services company. It provides range of products catering to critical care segment in Parental Section, such as Beta Lactam, Cephalosporin and General Dry powder Injectables, Ampoules and Liquid vials, and Dry Syrups and... (more)
No analyst recommendations are available for BROO.BO.
Overall
| Beta: | -- |
| Market Cap (Mil.): | Rs274.36 |
| Shares Outstanding (Mil.): | 16.19 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| BROO.BO | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 2.75 | 35.19 | 35.42 |
| EPS (TTM): | 6.16 | -- | -- |
| ROI: | -- | 19.50 | 18.86 |
| ROE: | -- | 20.27 | 19.73 |
Earnings vs. 
Estimates
No consensus analysis data available.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
